StockData
Airsculpt Technologies, Inc. logo

Airsculpt Technologies, Inc. (AIRS) stock

AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3084% below fair value
$0.74+0.04 (+5.53%)

Close on Nov 17, 2026Market cap $53.26MP/E –Yield –

Airsculpt Technologies r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Airsculpt Technologies

Airsculpt Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Airsculpt Technologies figures

See a number that looks wrong?